Antifungal agent 82 (compound G34) exhibits outstanding in vitro antifungal efficacy against Valsa mali, with an EC50 value of 0.57 µg/mL, and demonstrates excellent in vivo protective effects at 40 µg/mL [1].
Target:
Others
* VAT and and shipping costs not included. Errors and price changes excepted
